Synthesis, biological evaluation, X-ray molecular structure and molecular docking studies of RGD mimetics containing 6-amino-2,3-dihydroisoindolin-1-one fragment as ligands of integrin αIIbβ₃

Bioorg Med Chem. 2013 Aug 1;21(15):4646-61. doi: 10.1016/j.bmc.2013.05.019. Epub 2013 May 22.

Abstract

A series of novel RGD mimetics containing phthalimidine fragment was designed and synthesized. Their antiaggregative activity determined by Born's method was shown to be due to inhibition of fibrinogen binding to αIIbβ₃. Molecular docking of RGD mimetics to αIIbβ₃ receptor showed the key interactions in this complex, and also some correlations have been observed between values of biological activity and docking scores. The single crystal X-ray data were obtained for five mimetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Biomimetic Materials / chemistry*
  • Biomimetic Materials / metabolism
  • Biomimetic Materials / pharmacology
  • Crystallography, X-Ray
  • Fibrinogen / antagonists & inhibitors
  • Fibrinogen / metabolism
  • Humans
  • Isoindoles / chemistry*
  • Isoindoles / metabolism
  • Isoindoles / pharmacology
  • Ligands
  • Models, Molecular
  • Molecular Docking Simulation
  • Molecular Structure
  • Oligopeptides / chemistry*
  • Oligopeptides / metabolism
  • Oligopeptides / pharmacology
  • Phthalimides / chemistry*
  • Phthalimides / metabolism
  • Phthalimides / pharmacology
  • Platelet Aggregation / drug effects
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex / chemistry*
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Protein Binding

Substances

  • Isoindol-1-one
  • Isoindoles
  • Ligands
  • Oligopeptides
  • Phthalimides
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • phthalimidine
  • arginyl-glycyl-aspartic acid
  • Fibrinogen